Growth Metrics

Ocugen (OCGN) EPS (Weighted Average and Diluted) (2017 - 2025)

Ocugen (OCGN) has disclosed EPS (Weighted Average and Diluted) for 9 consecutive years, with $0.12 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 116.9% year-over-year to $0.12, compared with a TTM value of -$0.83 through Sep 2025, down 822.22%, and an annual FY2024 reading of -$0.8, changed N/A over the prior year.
  • EPS (Weighted Average and Diluted) was $0.12 for Q4 2025 at Ocugen, up from -$0.07 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.17 in Q3 2023 and bottomed at -$0.71 in Q4 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.09, with a median of -$0.08 recorded in 2021.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 500.0% in 2021, then soared 254.55% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.08 in 2021, then plummeted by 37.5% to -$0.11 in 2022, then skyrocketed by 254.55% to $0.17 in 2023, then plummeted by 517.65% to -$0.71 in 2024, then soared by 116.9% to $0.12 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for OCGN at $0.12 in Q4 2025, -$0.07 in Q3 2025, and -$0.05 in Q1 2025.